Li Zhao, Hong-Yan Gu, Jia Wang, Lei Tao, Rong Mu, Qing-Long Guo, Xiao-Nan Zhang
언어
영어(ENG)
URL
https://www.earticle.net/Article/A103085
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Three traditional Chinese medicines, Agrimonia pilosa Ledeb, Grifola umbellata (pers.) Pilat, and Gambogia, arecombined to form a compound extract, AGC. In this study, the in vitro and in vivo inhibitory effects of AGC on human gastriccarcinoma MGC-803 cells were demonstrated, and the molecular mechanisms underlying these effects are investigated. Ourresults indicate that AGC inhibited MGC-803 cell growth in a dose-dependent manner as measured by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, with an IC50 of about 6.045±0.69µg/mL. In vivo, AGCinhibited growth of human gastric carcinoma in xenograft tumors in nude mice, and the inhibitory rate reached 55.2% at 300mg/kg. The pro-apoptotic activity of AGC was attributed to its ability to decrease the expression of Bcl-2 and Pro-caspase3and increase the expression of Bax. These results demonstrate that AGC can effectively induce programmed cell death andmay be a promising anti-tumor drug in human gastric carcinoma.
목차
Abstract Introduction Materials and Methods Results and Discussion References
Li Zhao [ Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, PR China ]
Xiao-Nan Zhang [ Department of Pharmacology, the Fourth Military Medical University, Xi’an 710032, PR China ]
Hong-Yan Gu [ Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, PR China ]
Jia Wang [ Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, PR China ]
Lei Tao [ Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, PR China ]
Rong Mu [ Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, PR China ]
Qing-Long Guo [ Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, PR China ]
Corresponding author